Related references
Note: Only part of the references are listed.Systemic sclerosis
Elizabeth R. Volkmann et al.
LANCET (2023)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
Efficacy and safety of oral pulmonary vasodilators in pulmonary veno-occlusive disease
Junichi Nakamura et al.
PULMONARY CIRCULATION (2022)
Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances
Masaru Kato et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis
Keita Ninagawa et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Shikha Gupta et al.
ERJ OPEN RESEARCH (2019)
Response by Hadinnapola et al to Letter Regarding Article, Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Charaka Hadinnapola et al.
CIRCULATION (2018)
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
Esther J. Nossent et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction
Ahmed U. Fayyaz et al.
CIRCULATION (2018)
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Maria-Rosa Ghigna et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry
S. Rajaram et al.
THORAX (2015)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis
Aya Miura et al.
CARDIOVASCULAR PATHOLOGY (2013)
Computed Tomography Findings of Pulmonary Venoocclusive Disease in Scleroderma Patients Presenting With Precapillary Pulmonary Hypertension
S. Guenther et al.
ARTHRITIS AND RHEUMATISM (2012)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis
Vincent Thomas de Montpreville et al.
VIRCHOWS ARCHIV (2008)
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
Peter Dorfmueller et al.
HUMAN PATHOLOGY (2007)
Share Paper
